- Report
- November 2025
- 160 Pages
Global
From €2947EUR$3,358USD£2,549GBP
€3467EUR$3,950USD£2,999GBP
- Report
- May 2026
United States
From €3502EUR$3,990USD£3,029GBP
From €3502EUR$3,990USD£3,029GBP
- Report
- May 2026
Middle East
From €3502EUR$3,990USD£3,029GBP
- Report
- May 2026
Asia Pacific
From €3502EUR$3,990USD£3,029GBP
- Report
- August 2025
- 185 Pages
Global
From €3112EUR$3,545USD£2,691GBP
€3457EUR$3,939USD£2,990GBP
- Report
- May 2026
- 268 Pages
Global
From €4784EUR$5,450USD£4,137GBP
- Report
- February 2026
- 250 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 227 Pages
Global
From €2194EUR$2,500USD£1,898GBP
- Report
- April 2023
- 120 Pages
Global
From €4169EUR$4,750USD£3,606GBP
From €3502EUR$3,990USD£3,029GBP
- Report
- May 2026
United Kingdom
From €3502EUR$3,990USD£3,029GBP
From €3502EUR$3,990USD£3,029GBP
- Report
- May 2026
North America
From €3502EUR$3,990USD£3,029GBP
From €3502EUR$3,990USD£3,029GBP
The Blood Grouping Reagent market is a subset of the Blood Banking industry. It is composed of products used to identify the ABO and Rh blood group of a patient. These reagents are used to determine the compatibility of a patient's blood with a potential donor's blood, and are essential for successful transfusions. The market is composed of a variety of reagents, including monoclonal and polyclonal antibodies, lectins, and enzymes. These reagents are used in a variety of tests, such as agglutination, precipitation, and ELISA.
The Blood Grouping Reagent market is highly competitive, with a number of companies offering a wide range of products. Some of the major players in the market include Immucor, Grifols, Ortho Clinical Diagnostics, Bio-Rad Laboratories, and DiaMed. Show Less Read more
